All tenders

A--prevent IDIQ MATO RFP

Ref US-75N91023R00024Advertised16 Sept 2024Closing 28 Feb 2023

Tender Description

Notice type: Solicitation · NAICS 541714 · PSC AN12 Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing. See attached for additional details.

Country
United States
Published
16 Sept 2024
Closing date
28 Feb 2023
Procedure
Solicitation
Predictive Analytics
Notice sources
Tender updates

Update history (5)

Field-level amendments detected by TenderHive monitoring at each harvest of the source portal.

  1. us_samgov5 fields changed
    • Scope of works

      Notice type: Presolicitation · NAICS 541714 · PSC AN12 The overall objective of the current acquisition, designated as the PREVENT Cancer Preclinical Drug Development Program, is to provide a structured approach to drug…

      Notice type: Solicitation · NAICS 541714 · PSC AN12 Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermedi…

    • Submission deadline

      20 Feb 2023

      28 Feb 2023

    • Notice type

      prequalification

      tender

    • Procedure

      Presolicitation

      Solicitation

    • Source notice URL

      https://sam.gov/opp/c198f4fd245b4949acdb8082a9de4fe9/view

      https://sam.gov/opp/3fca19a50da6422c9e851d530af91d68/view

  2. us_samgov3 fields changed
    • Scope of works

      Notice type: Presolicitation · NAICS 541714 · PSC AN12 Planning 30 Days for RFP open period. Questions will be due by 18 Jan 2023, Not Later Than (NLT) 3:00 PM Eastern Time. The overall objective of the current acquisit…

      Notice type: Presolicitation · NAICS 541714 · PSC AN12 The overall objective of the current acquisition, designated as the PREVENT Cancer Preclinical Drug Development Program, is to provide a structured approach to drug…

    • Submission deadline

      06 Feb 2023

      20 Feb 2023

    • Source notice URL

      https://sam.gov/opp/28cad30a765049f4b35ad06f1360ba4b/view

      https://sam.gov/opp/c198f4fd245b4949acdb8082a9de4fe9/view

  3. us_samgov6 fields changed
    • Notice title

      PREVENT IDIQ MATO RFP

      A--PREVENT IDIQ MATO RFP

    • Scope of works

      Notice type: Solicitation · NAICS 541714 · PSC AN12 This solicitation, 75N91023R00024, is for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinic…

      Notice type: Presolicitation · NAICS 541714 · PSC AN12 Planning 30 Days for RFP open period. Questions will be due by 18 Jan 2023, Not Later Than (NLT) 3:00 PM Eastern Time. The overall objective of the current acquisit…

    • Submission deadline

      21 Feb 2023

      06 Feb 2023

    • Notice type

      tender

      prequalification

    • Procedure

      Solicitation

      Presolicitation

    • Source notice URL

      https://sam.gov/opp/b6bb012d59694a46b584dba6a4e4a3d7/view

      https://sam.gov/opp/28cad30a765049f4b35ad06f1360ba4b/view

  4. us_samgov4 fields changed
    • Notice title

      A--PREVENT IDIQ MATO RFP

      PREVENT IDIQ MATO RFP

    • Scope of works

      Notice type: Solicitation · NAICS 541714 · PSC AN12 Amendment 01 Q&A for solicitation, 75N91023R00024, is for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Bioma…

      Notice type: Solicitation · NAICS 541714 · PSC AN12 This solicitation, 75N91023R00024, is for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers, Preclinic…

    • Submission deadline

      27 Feb 2023

      21 Feb 2023

    • Source notice URL

      https://sam.gov/opp/894c7c40549849229a0412fc2d26a5ec/view

      https://sam.gov/opp/b6bb012d59694a46b584dba6a4e4a3d7/view

  5. us_samgov3 fields changed
    • Scope of works

      Notice type: Solicitation · NAICS 541714 · PSC AN12 Amendment 02 is to issue minor changes to solicitation, 75N91023R00024, for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermedi…

      Notice type: Solicitation · NAICS 541714 · PSC AN12 Amendment 01 Q&A for solicitation, 75N91023R00024, is for the PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Bioma…

    • Submission deadline

      28 Feb 2023

      27 Feb 2023

    • Source notice URL

      https://sam.gov/opp/d3cf76bbf0a94629b5f0f9c9fb4d553c/view

      https://sam.gov/opp/894c7c40549849229a0412fc2d26a5ec/view